v3.24.3
Stock-Based Compensation (Tables)
 9 Months Ended
Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
Stock option activity for the nine months ended October 31, 2024 was as follows:
Number of
Shares		Weighted
Average
Exercise Price
Outstanding, January 31, 20241,212,704 $7.14 
Granted— — 
Expired or forfeited(1,375)12.06 
Exercised(290,917)7.58 
Outstanding, October 31, 2024920,412 $7.00 
Exercisable, October 31, 2024920,412 $7.00 
Fully vested or expected to vest, October 31, 2024920,412 $7.00 
Schedule of Nonvested Restricted Stock Units Activity
RSU activity during the nine months ended October 31, 2024 was as follows:
Number of
Shares		Weighted Average
Grant Date Fair
Value
Nonvested, January 31, 20245,626,125 $33.19 
Granted3,027,506 33.46 
Vested(1,581,387)33.59 
Forfeited(704,777)34.93 
Nonvested, October 31, 20246,367,467 $33.08 
Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of ESPP shares during the nine months ended October 31, 2023 and 2024 was estimated at the date of grant using the Black-Scholes option valuation model based on assumptions as follows for ESPP awards:
Nine Months Ended October 31,
20232024
Expected life (in years)0.500.50
Expected volatility
61.66% - 61.86%
38.70% - 38.91%
Expected dividends0.00%0.00%
Risk-free interest rate
4.77% - 5.53%
5.24% - 5.37%
Schedule of Share-Based Compensation Expense
Total stock-based compensation expense included in our unaudited condensed consolidated statements of operations were as follows:
Three Months Ended October 31,Nine Months Ended October 31,
2023202420232024
Cost of subscription revenues$515 $733 $1,314 $2,088 
Cost of professional services and other revenues2,571 2,940 6,660 8,699 
Sales and marketing4,153 4,394 11,194 12,534 
Research and development4,386 4,208 11,665 13,720 
General and administrative4,198 5,696 11,136 15,974 
Total stock-based compensation expense$15,823 $17,971 $41,969 $53,015